Pilocarpine and Brimonidine in Patients With Monofocal Lenses
| Status: | Recruiting |
|---|---|
| Conditions: | Ocular, Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 60 - Any |
| Updated: | 2/2/2019 |
| Start Date: | January 21, 2019 |
| End Date: | December 31, 2019 |
| Contact: | Matthew Gardiner, MD |
| Email: | Matthew_Gardiner@meei.harvard.edu |
| Phone: | 617-573-3202 |
Effectiveness of Pilocarpine and Brimonidine to Improve Near Visual Acuity in Patients With Monofocal Intraocular Lenses
The current study aims to assess the use of pilocarpine and brimonidine to improve near
visual acuity in patietns with monofocal intraocular lenses. Thirty-three subjects with be
enrolled and baseline visual acuity with be measured at near and distance. This will be
compared to visual acuity after drop administration over 6 hours. A quality of life
questionnaire will also be evaluated.
visual acuity in patietns with monofocal intraocular lenses. Thirty-three subjects with be
enrolled and baseline visual acuity with be measured at near and distance. This will be
compared to visual acuity after drop administration over 6 hours. A quality of life
questionnaire will also be evaluated.
This research study will try to find out if pilocarpine and brimonidine can help people with
intraocular lens implants read without reading glasses. Thirty-three subjects will take part
in this research study. Baseline visual acuity with be measured at near and distance. This
will be compared to visual acuity after drop administration over 6 hours. A quality of life
questionnaire will also be evaluated.All subjects will take part at Massachusetts Eye and Ear
Infirmary (MEEI).
intraocular lens implants read without reading glasses. Thirty-three subjects will take part
in this research study. Baseline visual acuity with be measured at near and distance. This
will be compared to visual acuity after drop administration over 6 hours. A quality of life
questionnaire will also be evaluated.All subjects will take part at Massachusetts Eye and Ear
Infirmary (MEEI).
Inclusion Criteria:
- Individuals must meet all of the inclusion criteria in order to be eligible to
participate in the study. Men and women between ages 60 years and above with monofocal
intraocular lenses bilaterally corrected for distance and +/- 0.5D sphere vision who
need only +/- 2.5 D correction for reading. Given the age group selected only post
menopausal women will be evaluated.
Exclusion Criteria:
- Individuals meeting any of the exclusion criteria at baseline will be excluded from
study participation including: allergies to proparacaine, pilocarpine or brimonidine,
eye infection or inflammation, glaucoma, retinal tear or retinal disease, eye surgery
within the past 30 days, use of eye drops within the last seven days, participated in
any other research study within the past 30 days. Patients using contact lenses.
We found this trial at
1
site
Click here to add this to my saved trials
